Surgery, Gastroenterology and Oncology
Vol. 23, No. 2, Apr 2018
Red-flag Techniques for the Assessment of Pre-Neoplastic Gastric Lesions: Autofluorescence Imaging versus Virtual Chromoendoscopy
Maria Monalisa Filip, Sevastiţa Iordache, Elena Daniela Burtea, Mihaela Căliţa, Adrian Săftoiu
ORIGINAL PAPER, Apr 2018
Article DOI: 10.21614/sgo-23-2-115
Background Aim: The endoscopic diagnosis of preneoplastic lesions and early gastric cancer is based on subtle morphological changes, which are difficult to recognize during routine examinations. The study was performed in order to establish the role of autofluorescence imaging (AFI) and magnifying endoscopy with narrow band imaging (ME-NBI) for the diagnosis of premalignant gastric lesions.

Methods: The study included patients with dyspeptic symptoms and or known risk factors for gastric cancer. Imaging consisted of white light endoscopy (WLE), followed by AFI and ME-NBI. Targeted biopsies were taken from all the highlighted lesions, regardless of the method. A statistical analysis was performed to compare the results.

Results: Sensitivity of AFI (94.74%) was superior to WLE and ME-NBI (78.95%). Specificity of AFI (65.33%) was however lower than the ME-NBI and WLE, with an accuracy of 71.27%. ME-NBI has high sensitivity, a much better specificity than AFI (92%) and a diagnostic accuracy of 89.36%. Trimodal endoscopy had an accuracy of 92.55%, which was superior to all other methods.
Nevertheless, ME-NBI use had reduced the percentage of false positives from 27.65% to 6.38%, thus increasing specificity.

Conclusion: Trimodal endoscopy could be proposed as a standard endoscopic technique, as it is quick, safe and accurate for the diagnosis and surveillance of premalignant and malignant upper gastrointestinal tract lesions.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 3382


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.